Pharma-Bio Serv, Inc. PBSV

Company Overview

Pharma-Bio Serv, Inc. (NASDAQ: PBSV) is a Puerto Rico–based life sciences services company that provides regulatory compliance, validation, quality consulting, engineering, and technology-enabled services primarily to pharmaceutical, biotechnology, medical device, and healthcare manufacturers. The company operates in industries tied to regulated manufacturing and laboratory environments, supporting clients that must comply with standards established by agencies such as the U.S. Food and Drug Administration (FDA) and other international regulators. Its revenue is primarily generated through consulting engagements, technical services, staffing support, quality assurance programs, and laboratory-related operations.

PBSV’s business model centers on supporting highly regulated production and operational environments, particularly in Puerto Rico and selected U.S. markets where pharmaceutical and medical device manufacturing activity is concentrated. The company has evolved from a technical compliance and validation services provider into a broader operational support organization serving life sciences manufacturers across multiple stages of production and commercialization. Its positioning benefits from longstanding relationships in Puerto Rico’s pharmaceutical manufacturing ecosystem, where many multinational drug and device companies maintain facilities.

Business Operations

PBSV operates through service-oriented business units that provide validation and compliance consulting, engineering support, quality systems management, environmental monitoring, laboratory support, and technical staffing services. Its operations include services associated with manufacturing process validation, computer systems validation, quality assurance audits, calibration, maintenance support, and operational readiness for regulated facilities. The company also operates laboratory and compliance-related capabilities through subsidiaries and affiliated operating entities supporting pharmaceutical and biotechnology clients.

The company generates revenue from recurring service contracts, project-based consulting engagements, staffing assignments, and regulated operational support services. PBSV’s operations are concentrated primarily in Puerto Rico and the United States, though it has also pursued business opportunities linked to multinational pharmaceutical production networks. The company has historically maintained relationships with major pharmaceutical and medical device manufacturers operating on the island, and its operational model emphasizes specialized technical expertise, regulatory familiarity, and workforce deployment capabilities in regulated environments.

Strategic Position & Investments

PBSV’s strategic direction has focused on expanding higher-margin technical and compliance services while strengthening its position within regulated life sciences manufacturing markets. Public filings and company disclosures indicate ongoing efforts to diversify service offerings tied to quality systems, validation technologies, laboratory operations, and technical staffing. The company has also pursued operational efficiency initiatives and selective investments intended to support scalable recurring revenue opportunities within pharmaceutical manufacturing support services.

The company has historically used acquisitions, partnerships, and subsidiary structures to broaden its capabilities and client reach. Its strategy has included investments in technical service expansion and support for emerging pharmaceutical manufacturing requirements, including data integrity, computerized systems compliance, and advanced quality management processes. While PBSV remains relatively small compared with larger global engineering and compliance firms, its niche specialization within regulated manufacturing environments and its established regional presence remain central to its competitive positioning.

Geographic Footprint

PBSV is headquartered in Puerto Rico, which serves as the company’s primary operational hub and largest market presence. Puerto Rico remains a major global center for pharmaceutical and medical device manufacturing, and PBSV’s longstanding presence there has positioned the company to support multinational manufacturers operating facilities across the island. The company also maintains operations and business activities within the continental United States.

The company’s operational influence is tied largely to regions with significant pharmaceutical and biotechnology manufacturing activity. Although PBSV is not considered a large multinational enterprise, its client base has included companies with international operations, providing indirect exposure to broader global pharmaceutical supply chains. Public disclosures indicate that the company continues to evaluate opportunities for expansion tied to regulated manufacturing and compliance support markets.

Leadership & Governance

PBSV is governed by a board of directors and executive leadership team responsible for operational oversight, regulatory compliance, strategic growth, and financial management. The company’s leadership approach has emphasized technical specialization, client service continuity, and long-term participation in the regulated life sciences manufacturing sector. Corporate governance practices are disclosed through periodic filings with the U.S. Securities and Exchange Commission, including annual reports and proxy statements.

Key executives identified through recent public filings include:

• Marlene M. Cruz – President and Chief Executive Officer
• Richard A. deCastro – Chief Financial Officer
• Pedro R. Ortiz – Executive Vice President
• Jorge A. Negrón – Senior operational and technical executive roles reported in company disclosures

Certain executive role assignments and board compositions may change over time based on subsequent company filings and disclosures.